The Smokefree Support Study 2.0 study protocol paper, “Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices,” is now available to read online at BMC Public Health! Persistent smoking among patients diagnosed with Read more…
Congratulations to HPRIR faculty member Daniel Hall, PhD, who has been invited to speak at the MGH Cancer Center Oncology APP Education Series! A focus group of oncology APPs partnered with GU medical oncologist Phil Saylor in October 2018 to Read more…
LTFU’s new HINT [Health Insurance Navigation Tools] Study is examining new ways to help cancer survivors understand, obtain, and take advantage of all their health insurance has to offer. “Health insurance coverage is a real stressor for long-term survivors,” explains Read more…
Congratulations to Giselle Lougee-Perez, Ph.D., who was selected to participate in the MGH Disparities Solutions Center Secondary Mentorship Program for Diverse Research Faculty. This one-year Pilot Program begins late June 2022 and will continue through June 2023. The Program pairs Read more…
Congratulations to Doug Levy et al. on the publication of article “Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer”. The objective of study was to estimate the incremental cost per quit (ICQ) of adopting an intensive smoking cessation Read more…
This month, a paper examining illness-uncertainty, among rheumatology patients, was published in the Journal of Rheumatology, led by Dr. Zack Wallace of the MGH Division of Rheumatology, Allergy, and Immunology with HPRIR faculty Dr. Lucy Finkelstein-Fox and Dr. Elyse Park Read more…
Elyse R. Park, PhD, MP.H and Professor of Psychiatry at Harvard Medical School presented at the 2022 ASCO Annual Meeting on the findings of the Childhood Cancer Survivor Study. The Study is a collaboration with the Childhood Cancer Survivor Study Read more…
Dr. Angela Walter presented on neighborhood disadvantage and tobacco use among adults with cancer in the U.S. at the 2022 American Society of Clinical Oncology [ASCO] Annual Meeting in Chicago. The results Dr. Walter presented span 10 ECOG-ACRIN trials which Read more…
On Thursday, June 23rd from 4:00pm-5:00pm, Dr. Giselle Perez will discuss the importance of attending to the post-treatment psycho-social needs of patients with cancer. Dr. Perez will summarize the Cancer Center’s current efforts to improve patient’s coping and resiliency after Read more…
Last week, at the ECOG-ACRIN Cancer Research Group annual conference, project director Dr. Brett Goshe (pictured above) presented trial updates for the EAQ171CD Smoke Free Support Study 2.0. The Smoke Free Support Study 2.0 is a trial designed to examine Read more…